|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 69.55 CHF | -1.35% |
|
-5.95% | -33.94% |
| 01:25am | Cosmo Pharmaceuticals Flags Launch of Acne Treatment in Key Markets Across Europe | MT |
| 06-09 | Berenberg Reiterates Cosmo Pharmaceuticals' Buy Rating on Partnership Potential | MT |
| Market Cap | 1.24B 1.43B 1.14B 1.07B 1.99B 136B 2.04B 13.56B 5.26B 66B 5.37B 5.25B 230B | P/E Ratio 2026 * |
969x | P/E Ratio 2027 * | 26x |
|---|---|---|---|---|---|
| Enterprise Value | 1.21B 1.4B 1.11B 1.04B 1.94B 133B 1.99B 13.23B 5.13B 64.39B 5.24B 5.13B 224B | EV / Sales 2026 * |
11.2x | EV / Sales 2027 * | 6.77x |
| Free-Float |
39.91% | Yield 2026 * |
2.78% | Yield 2027 * | 2.95% |
Last Transcript: Cosmo N.V.
| 1 day | -1.35% | ||
| 1 week | -5.95% | ||
| Current month | -10.90% | ||
| 1 month | -6.84% | ||
| 3 months | -25.99% | ||
| 6 months | -27.45% | ||
| Current year | -33.94% |
| 1 week | 67.9 |  | 74.6 |
| 1 month | 67.9 | | 81.2 |
| Current year | 67.9 | | 129.4 |
| 1 year | 53.4 | | 129.4 |
| 3 years | 33.7 | | 129.4 |
| 5 years | 33.7 | | 129.4 |
| 10 years | 33.7 | | 188.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 2024-05-23 | |
| Director of Finance/CFO | - | 2024-11-10 | |
Paolo Lanzarotti
CTO | Chief Tech/Sci/R&D Officer | 53 | 2008-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mauro Ajani
CHM | Chairman | 71 | 2013-12-31 |
| Director/Board Member | 71 | 2012-03-31 | |
Niall Donnelly
BRD | Director/Board Member | 54 | 2024-05-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-10 | Sell | -30,000 | 0.1710% | |||
| 04-21 | Sell | 4,000 | 0.0228% | |||
| 04-20 | Sell | 10,500 | 0.0599% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.35% | -5.95% | +15.45% | +44.79% | 1.43B | |
| +2.37% | +3.54% | +44.08% | +161.63% | 1,013B | |
| +0.65% | +5.30% | +54.74% | +50.25% | 574B | |
| +0.50% | +0.58% | +18.15% | +64.27% | 397B | |
| -0.37% | +4.97% | +21.24% | +15.95% | 324B | |
| +0.70% | +0.10% | +24.41% | +14.69% | 280B | |
| +2.07% | +5.04% | +25.44% | +33.95% | 273B | |
| +3.54% | +0.97% | +19.58% | +60.54% | 182B | |
| -0.19% | -0.46% | -45.32% | -48.35% | 194B | |
| +3.45% | -2.62% | +15.09% | +61.56% | 151B | |
| Average | +1.13% | +2.19% | +19.29% | +45.93% | 339.01B | |
| Weighted average by Cap. | +1.39% | +3.99% | +29.80% | +73.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 107M 124M 99.07M 92.68M 173M 11.83B 177M 1.18B 456M 5.73B 466M 456M 19.92B | 179M 206M 165M 154M 287M 19.66B 294M 1.96B 758M 9.52B 774M 758M 33.1B |
| Net income | 1.46M 1.68M 1.34M 1.26M 2.35M 160M 2.4M 15.97M 6.19M 77.72M 6.32M 6.19M 270M | 50.02M 57.79M 46.11M 43.14M 80.5M 5.51B 82.31M 548M 212M 2.67B 217M 212M 9.27B |
| Net Debt | -30.2M -34.89M -27.84M -26.05M -48.6M -3.32B -49.69M -331M -128M -1.61B -131M -128M -5.6B | -28.83M -33.31M -26.58M -24.86M -46.4M -3.17B -47.44M -316M -122M -1.54B -125M -122M -5.34B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-11 | 69.50 CHF | -1.42% | 24,588 |
| 26-06-10 | 70.50 CHF | +1.59% | 51,654 |
| 26-06-09 | 69.40 CHF | -1.98% | 25,540 |
| 26-06-08 | 70.80 CHF | -2.75% | 24,439 |
| 26-06-05 | 72.80 CHF | -1.49% | 15,383 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COPN Stock
Select your edition
All financial news and data tailored to specific country editions
